Sitagliptin Metformin XR Spirig HC 50/500 mg
As listed in the register: Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung
500 mg ·
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Metformini hydrochloridum + Sitagliptinum
- Made by
- Spirig HealthCare AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Antidiabetikum
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Spirig HealthCare AG |
|---|---|
| Active substance | Metformini hydrochloridum + Sitagliptinum |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 500 mg |
| Classification | A10BD07 · Digestion, stomach, diabetes and nutrition |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Sitagliptin Metformin XR Spirig HC 50/500 mg, Tabletten mit veränderter Wirkstofffreisetzung |
| Packs | 60 Tablette(n) · 160 Tablette(n) |
| Zulassungsnummer | 69160 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Metformini hydrochloridum + Sitagliptinum